1
|
Italiano A, Sung YS, Zhang L, Singer S,
Maki RG, Coindre JM and Antonescu CR: High prevalence of CIC fusion
with double-homeobox (DUX4) transcription factors in EWSR1-negative
undifferentiated small blue round cell sarcomas. Genes Chromosomes
Cancer. 51:207–218. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Antonescu CR, Owosho AA, Zhang L, Chen S,
Deniz K, Huryn JM, Kao YC, Huang SC, Singer S, Tap W, et al:
Sarcomas with CIC-rearrangements are a distinct pathologic entity
with aggressive outcome: A clinicopathologic and molecular study of
115 cases. Am J Surg Pathol. 41:941–949. 2017. View Article : Google Scholar
|
3
|
Le Guellec S, Velasco V, Pérot G, Watson
S, Tirode F and Coindre JM: ETV4 is a useful marker for the
diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: A
study of 127 cases including mimicking lesions. Mod Pathol.
29:1523–1531. 2016. View Article : Google Scholar
|
4
|
Richkind KE, Romansky SG and Finklestein
JZ: t(4;19)(q35;q13.1): A recurrent change in primitive mesenchymal
tumors? Cancer Genet Cytogenet. 87:71–74. 1996. View Article : Google Scholar
|
5
|
Haidar A, Arekapudi S, DeMattia F, Abu-Isa
E and Kraut M: High-grade undifferentiated small round cell sarcoma
with t(4;19)(q35;q13.1) CIC-DUX4 fusion: Emerging entities of soft
tissue tumors with unique histopathologic features-A case report
and literature review. Am J Case Rep. 16:87–94. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Loarer FL, Pissaloux D, Watson S,
Godfraind C, Galmiche-Rolland L, Silva K, Mayeur L, Italiano A,
Michot A, Pierron G, et al: Clinicopathologic features of CIC-NUTM1
sarcomas, a new molecular variant of the family of CIC-fused
sarcomas. Am J Surg Pathol. 43:268–276. 2019. View Article : Google Scholar
|
7
|
Lokuhetty D, White VA and Cree IA: World
Health Organization Classification of Tumours: soft Tissue and Bone
Tumours. 5th edition. WHO Classification of Tumours Editorial
Board. International Agency for Research on Cancer (IARC); Argonay:
2020
|
8
|
Zhao L, Sun M, Lliu QY, Yu L and Wang J:
Clinicopathological analysis of 10 cases of CIC reordering sarcoma.
Chin J Pathol. 48:515–521. 2019.(In Chinese).
|
9
|
Brady EJ, Hameed M, Tap WD and Hwang S:
Imaging features and clinical course of undifferentiated round cell
sarcomas with CIC-DUX4 and BCOR-CCNB3 translocations. Skeletal
Radiol. 50:521–529. 2021. View Article : Google Scholar
|
10
|
Loarer FL, Pissaloux D, Coindre JM, Tirode
F and Vince DR: Update on families of round cell sarcomas other
than classical Ewing sarcomas. Surg Pathol Clin. 10:587–620. 2017.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Yoshida A, Goto K, Kodaira M, Kobayashi E,
Kawamoto H, Mori T, Yoshimoto S, Endo O, Kodama N, Kushima R, et
al: VCIC-rearranged sarcomas: A study of 20 cases and comparisons
with Ewing sarcomas. Am J Surg Pathol. 40:313–323. 2016. View Article : Google Scholar
|
12
|
Siegele B, Roberts J, Black JO, Rudzinski
E, Vargas SO and Galambos C: DUX4 immunohistochemistry is a highly
sensitive and specific marker for CIC-DUX4 fusion-positive round
cell tumor. Am J Surg Pathol. 41:423–429. 2017. View Article : Google Scholar
|
13
|
Oyama R, Takahashi M, Yoshida A, Sakumoto
M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, et al:
Generation of novel patient-derived CIC-DUX4 sarcoma xenografts and
cell lines. Sci Rep. 7:47122017. View Article : Google Scholar : PubMed/NCBI
|